Home | News | Find a Doctor | Ask a Question | Free

What about other HM research?


#1

Is there any current (let’s say from the last year) information about the work of Phoenixbio, Shishedo or any other non-ICX or Aderans HM protocol in development?

I know nothing about these companies or their research. It could be that there is some team of Korean, Chinese or Japanese researchers out there that we have been totally overlooking.


#2

» Is there any current (let’s say from the last year) information about the
» work of Phoenixbio, Shishedo or any other non-ICX or Aderans HM protocol
» in development?
»
» I know nothing about these companies or their research. It could be that
» there is some team of Korean, Chinese or Japanese researchers out there
» that we have been totally overlooking.

research, yes. progress and intention on releasing anything in the near future- no. ICX is our only hope. seems like everybody else uses HM as a buzz word to bring attention to their HT business.


#3

» »


#4

Or at least that’s what hoping, lol… anyone read Japanese???

Here’s the link with press releases:
http://www.phoenixbio.co.jp/index.html


#5

Hey,

Here’s a patent by PhoenixBio for HM from May of 2007:
http://www.wipo.int/pctdb/en/wo.jsp?wo=2007037486

Though we all know by know what a disappointment patents, are lol.

Here’s the abstract:
Disclosed is a method for cultivation of a hair follicular dermal sheath cell or a precursor cell thereof which is a potential cellular material for hair regeneration by cell transplantation. The method comprises the step of cultivating a hair follicular dermal sheath cell or a precursor cell thereof in an animal cell culture medium supplemented with a platelet-derived growth factor AA (PDGF-AA) and a fibroblast growth factor 2 (FGF2). As a result, the hair follicular dermal sheath cell can be proliferated while maintaining its functions, or the precursor cell can be differentiated into a hair follicular dermal sheath cell and proliferated.


#6

Development of hair regeneration treatment by autografting cultured papilla cells

Hair (hair shaft) is produced from hair follicles, which are transformed skin tissue. Roughly divided, a hair follicle consists of epidermal cells and dermal cells, and epidermal cells change to form a hair follicle at the command of dermal papilla cells. Taking advantage of this function, hair regeneration is possible if dermal papilla cells are transplanted to the skin.

For the purpose of treating hair loss such as male pattern alopecia and alopecia areata, in cooperation with clinical sites, PhoenixBio is researching the practical application of the hair regeneration technique in which patientsユ own dermal papilla cells are cultured and propagated in vitro, and then autografted onto their skin.

Stabilization of Management Base

PhoenixBio received a total investment of 570 million yen in 2004 to stabilize its management base. These funds are being used for construction of a facility for chimeric mouse production and research, hair regeneration R&D and staff enhancement.

Sounds like everybody else. I wouldn’t discount the Japanese. When they get on a problem, they work to solve it steadfastly.